The metabolic axis of Alzheimer’s disease pathophysiology involves dysregulated Aβ/Tau proteostasis, glia-driven neuroinflammatory cascades, mitochondrial dysfunction, ferroptosis, and oxidative stress pathways, which synergistically propagate a self-sustaining cycle of neurodegenerative progression [3,4,5]. Here, MAPT is linked to Alzheimer disease.